Chicago, IL 的 結腸癌 臨床試驗
14 項針對 結腸癌 的研究正在 Chicago（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Family Communications After Genetic Testing
招募中歡迎健康志工
- Advocate Illinois Masonic Medical Center, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
招募中1/2 期
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Illinois Cancer Specialists, Chicago
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- University of Illinois Cancer Center, Chicago
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
招募中
- John H Stroger Jr Hospital of Cook County, Chicago
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
招募中2/3 期
- Mount Sinai Hospital Medical Center, Chicago
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- 還有 5 項
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
招募中1/2 期
- Northwestern University, Chicago
Shield Post-Approval Study Protocol
招募中觀察性研究歡迎健康志工
- GI Solutions of Illinois, Chicago
- GI Solutions of Illinois, Chicago
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
招募中1 期
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
招募中2 期
- City of Hope at Illinois Chicago Downtown, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- University of Chicago, Chicago
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
招募中觀察性研究歡迎健康志工
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
招募中3 期
- GSK Investigational Site, Chicago
- GSK Investigational Site, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Chicago
其他城市的 結腸癌 試驗
- Boston, MA22 項研究
- New York City, NY22 項研究
- Houston, TX20 項研究
- Los Angeles, CA16 項研究
- Nashville, TN16 項研究
- St. Louis, MO15 項研究
- Arlington, VA15 項研究
- San Antonio, TX14 項研究
- Baldwin Park, CA14 項研究
- Baltimore, MD13 項研究
- Tampa, FL13 項研究
- Washington, DC12 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌59 項研究
- 癌症（所有類型）51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肺癌41 項研究
- 肥胖症41 項研究
- 卵巢癌36 項研究
- 大腸直腸癌34 項研究
- 中風34 項研究
- 心臟衰竭31 項研究
- 過重29 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。